Editorial: Community series - Purple Haze: issues on cannabis legalization, volume II

Front Psychiatry. 2023 Jul 21:14:1241229. doi: 10.3389/fpsyt.2023.1241229. eCollection 2023.

Stéphane Potvin^{1

2}, Yasser Khazaal^{1

2

3}, Amine Benyamina⁴, Marc N Potenza^{5

6

7

8}

¹ Centre de recherche de l'Institut Universitaire en Santé Mentale de Montréal, Montreal, QC, Canada.
² Department of Psychiatry and Addiction, University of Montreal, Montreal, QC, Canada.
³ Addiction Medicine, Department of Psychiatry, Lausanne University Hospital and Lausanne University, Lausanne, Switzerland.
⁴ Department of Psychiatry and Addictology, Hospital Paul Brousse Villejuif, Unité Psychiatrie-Comorbidités-Addictions-Unité de Recherche PSYCOMADD 4872, Université Paris Saclay, Villejuif, France.
⁵ Connecticut Mental Health Center, New Haven, CT, United States.
⁶ Connecticut Council on Problem Gambling, Wethersfield, CT, United States.
⁷ Wu Tsai Institute, Yale University, New Haven, CT, United States.
⁸ Department of Psychiatry, Child Study and Neuroscience, Yale School of Medicine, New Haven, CT, United States.

No abstract available

Keywords: cannabis; harm reduction; legalization; policy; public health.

Publication types